Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases

Abstract Submission

The Organizing Committee invites you to submit an abstract of your scientific research to be considered for inclusion in the poster session on September 12. In addition, up to three authors will be selected to give oral presentations. Notice of acceptance for the oral presentations and poster session will be sent to authors by August 15.

Please submit your abstract no later than August 1.

Preparation/Formatting Guidelines

Abstracts should provide clear data and validated conclusions. They should consist of an introduction that presents the background of the study, a brief description of the methods employed, a summary of the results, and a statement of the conclusions.
Please use the following format for your abstract’s file name: "Abstract_Submitter Name"
Abstracts should contain a maximum of 300 words.
Submissions should be in Word, using 12 point Arial font, with 1.5" margins (left, right, bottom, top).
The following information must appear at the top: Abstract title, names, and affiliations of authors with the name of presenter in bold.

Example:
John Doe¹, Mary Smith², Peter Jones³. ¹National Cancer Institute, ²Channing Laboratory, Harvard University and ³University of California, San Francisco

Submission Guidelines

Please submit your abstract through the registration website no later than August 1. Use the following file name format: "Abstract_Submitter's Name."

In the body of your abstract, please include:

Name and degree(s)
Position Title, Department, Affiliation
Mailing Address
Telephone, E-mail

If you have questions regarding the online submission, please contact Ann Walsh at walshac@nhlbi.nih.gov or 508-663-4046.

Twitter

Facebook

YouTube

Google+